Yvonne Wengström
E-postadress: yvonne.wengstrom@ki.se
Besöksadress: Alfred Nobels Allé 23 Flemingsberg, Sektionen för Omvårdnad, 14183 Huddinge
Postadress: H1 Neurobiologi, vårdvetenskap och samhälle, H1 Omvårdnad Wengström, 171 77 Stockholm
Artiklar
- Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2026;83:103211Mijwel S; Backman M; Anandavadivelan P; Tofthagen C; Wengstrom Y
- Article: EUROPEAN JOURNAL OF ONCOLOGY NURSING. 2026;82:103187Holmberg K; Bergkvist K; Winterling J; Kisch AM; Wengstrom Y; Hagelin CL
- Article: PSYCHO-ONCOLOGY. 2026;35(4):e70457de Jongh ECE; Depenbusch J; May A; Hiensch A; Wengstrom Y; Belloso J; Lachowicz M; van de Poll-Franse L; Steindorf K; Stuiver MM
- Article: SUPPORTIVE CARE IN CANCER. 2026;34(5):429Hagelin CL; Kisch AM; Holmberg K; O'Sullivan A; Wengstrom Y; Winterling J; Bergkvist K
- Article: BREAST CANCER RESEARCH. 2026;28(1):98Zopf EM; Joernaker G; Clauss D; Trevaskis M; Hiensch AE; Schmidt ME; Monninkhof EM; Zimmer P; Belloso J; Heyrman E; Gonzalo RF; Wiskemann J; Mueller J; Bolam KA; Gorecki M; Altena R; Muttiah C; van der Wall E; Aaronson NK; Senkus E; Urruticoechea A; Stuiver MM; Steindorf K; Bloch W; Wengstrom Y; May AM; Rundqvist H
- Article: JOURNAL OF CANCER SURVIVORSHIP. 2025;19(6):2110-2118Holmberg K; Bergkvist K; Wengstrom Y; Hagelin CL
- Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. MONOGRAPHS. 2025;2025(71):351-359Considerations for delivery of live-remote exercise for people with cancer in research and practice.Zopf EM; Müller J; Trevaskis M; Kias A; Hiensch AE; Bland KA; Lorenz MC; Monninkhof EM; Schmidt ME; Binyam D; Clauss D; Gunasekara N; Crisafio M; De Jongh E; Olivier F; Wengström Y; Steindorf K; Alves AJC; Campbell A; Campbell KL; Stuiver MM; May AM; Winters-Stone K
- Journal article: BJS-BRITISH JOURNAL OF SURGERY. 2025;112:znaf149.027Appelgren M; Sackey H; Lundholm C; Wengstrom Y; Hartmann S; Wihlfahrt K; Banys-Paluchowski M; Kuehn T; de Boniface J
- Article: INTERNATIONAL JOURNAL OF CANCER. 2025;157(3):490-503Schmidt ME; Hiensch AE; Depenbusch J; Monninkhof EM; Belloso J; Clauss D; Gunasekara N; Trevaskis M; Rundqvist H; Wiskemann J; Mueller J; Sweegers MG; Schneweiss A; Altena R; Kufel-Grabwska J; Bijlsma RM; van Leeuwen-Snoeks L; Huinink DTB; Sonke G; Brandner S; Savas P; Antill Y; White M; Ancizar N; van Der Wall E; Aaronson NK; Senkus E; Urruticoechea A; Zopf EM; Bloch W; Stuiver MM; Wengstroem Y; May AM; Steindorf K
- Article: CANCER MEDICINE. 2025;14(15):e71074Kias A; Schmidt ME; Hiensch AE; Clauss D; Monninkhof EM; Pelaez M; Belloso J; Gunasekara N; Sweegers MG; Trevaskis M; Rundqvist H; Mueller J; Wiskemann J; van Der Wall E; Aaronson NK; Lachowicz M; Urruticoechea A; Zopf EM; Bloch W; Stuiver MM; Wengstrom Y; May AM; Steindorf K
- Article: JOURNAL OF PSYCHOSOCIAL ONCOLOGY. 2025;43(4):513-529Odling M; Jervaeus A; Wengstrom Y; Rosenberg AR; Yi-Frazier JP; Winterling J
- Article: JOURNAL OF CANCER SURVIVORSHIP. 2025;:1-16Kotte M; Bolam KA; Altena R; Cormie P; Wengstrom Y; Mijwel S
- Article: JOURNAL OF ADVANCED NURSING. 2025;81(6):3156-3165Appelgren M; Wengstroem Y; de Boniface J; Sackey H
- Article: BMJ OPEN. 2025;15(4):e097814Vesterberg A; Asplund E; Marras G; Vujasinovic M; Haddad Ringborg C; Wengstrom Y; Lohr M
- Article: JOURNAL OF CLINICAL ONCOLOGY. 2025;43(11):1325-1336Schouten AEM; Hiensch AE; Frederix GWJ; Monninkhof EM; Schmidt ME; Clauss D; Gunasekara N; Belloso J; Trevaskis M; Rundqvist H; Wiskemann J; Mueller J; Sweegers MG; Fremd C; Altena R; Bijlsma RM; Sonke G; Lahuerta A; Mann GB; Francis PA; Richardson G; Malter W; Kufel-Grabowska J; van der Wall E; Aaronson NK; Senkus E; Urruticoechea A; Zopf EM; Bloch W; Stuiver MM; Wengstrom Y; Steindorf K; van der Meulen MP; May AM
- Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2025;117(4):629-636Hammarstrom M; Gabrielson M; Bergqvist J; Lundholm C; Crippa A; Backlund M; Wengstrom Y; Borgquist S; Eliasson E; Eriksson M; Tapia J; Czene K; Hall P
- Article: BMC HEALTH SERVICES RESEARCH. 2025;25(1):344Tapia J; Gabrielson M; Hammarstrom M; Wengstrom Y; Bergqvist J; Tuuliainen A; Eriksson M; Czene K; Hall P; Backlund M
- Article: CLINICAL NURSING RESEARCH. 2025;34(2):86-94O'Sullivan A; Hagelin CL; Holmberg K; Bergkvist K; Bala S-V; Wengstrom Y; Kisch AM; Winterling J
- Article: PATIENT EDUCATION AND COUNSELING. 2025;130:108479Stokholm RN; Kirkegaard P; Larsen MB; Lauridsen HH; Stacey D; Harper DM; Sepucha K; Mccaffery K; Reder M; Pignone M; Fransen M; Volk RJ; Wengstrom Y; Edwards A; Andersen B
- Article: HEALTH SERVICES INSIGHTS. 2025;18:11786329241310735O'Sullivan A; Winterling J; Kisch AM; Bergkvist K; Edvardsson D; Wengstrom Y; Hagelin CL
- Visa fler
Alla övriga publikationer
- Book chapter: COMPLEX INTERVENTIONS IN HEALTH. 2026;p. 171-175Wengström Y; Hallberg IR
- Book: 2026Richards DA; Rahm Hallberg I; Estabrooks C; Köpke S; Meyer G; Wallin L; Wengström Y; Woodford J
- Study protocol: TRIALS. 2025;26(1):540Hiensch AE; Muller J; Zopf EM; Schmidt ME; Monninkhof EM; Trevaskis M; Belloso J; Clauss D; Gunasekara N; Joaquim A; Viamonte S; Schumann M; Heinrich L; Kias A; Binyam D; Van De Poll L; Buffart LM; Aaronson NK; Van Der Wall E; Campbell A; Wiskemann J; Rundqvist H; Alves AJ; Urruticoechea A; Bloch W; Stuiver MM; Wengstrom Y; Steindorf K; May AM
- Conference publication: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. 2024;20:87-88Rundqvist H; Joernaker G; Clauss D; Trevaskis M; Hiensch AE; Schmidt ME; Monninkhof EM; Zimmer P; Belloso J; Heyrman E; Gonzalo RF; Wiskemann J; Mueller J; Altena R; Mann B; Francis P; Richardson G; Antill Y; White M; Savas P; van der wall E; Aaronson NK; Senkus E; Urruticoechea A; Stuiver MM; Steindorf K; Bloch W; Wengstrom Y; May AM; Zopf EM
- Conference publication: MEDICINE & SCIENCE IN SPORTS & EXERCISE. 2024;56(10):547Rietz M; Mijwel S; Wengstrom Y; Rundqvist H
- Conference publication: MEDICINE & SCIENCE IN SPORTS & EXERCISE. 2024;56(10):352May A; Monninkhof E; Schmidt M; Pelaez M; Gunasekara N; Clauss D; Belloso J; Rundqvist H; Wiskemann J; Mueller J; van der Wall E; Aaronson N; Senkus E; Urruticoechea A; Zopf E; Bloch W; Stuiver M; Wengstrom Y; Steindorf K; de Wit A; Hiensch A
- Conference publication: MEDICINE & SCIENCE IN SPORTS & EXERCISE. 2024;56(10):1024-1025Hiensch A; Depenbusch J; Schmidt M; Clauss D; Monninkhof E; Pelaez M; Zimmer P; Belloso J; Gunasekara N; Sweegers M; Trevaskis M; Rundqvist H; Wiskemann J; Mueller J; van der Wall E; Aaronson N; Senkus E; Urruticoechea A; Zopf E; Bloch W; Stuiver M; Wengstrom Y; Steindorf K; May A
- Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(16)Hiensch AE; Schouten A; Monninkhof EM; Schmidt M; Clauss D; Trevaskis M; Rundqvist H; Wiskemann J; Mueller J; Van der Wall E; Aaronson NK; Senkus-Konefka E; Urruticoechea A; Bloch W; Zopf E; Stuiver MM; Wengstrom Y; Steindorf K; van der Meulen M; May AM
- Preprint: RESEARCH SQUARE. 2024Holmberg K; Bergkvist K; Wengström Y; Hagelin CL
- Preprint: RESEARCH SQUARE. 2024Tapia J; Gabrielson M; Hammarström M; Wengström Y; Bergqvist J; Tuuliainen A; Eriksson M; Czene K; Hall P; Bäcklund M
- Conference publication: ONCOLOGY RESEARCH AND TREATMENT. 2024;47:199Depenbusch J; Hiensch AE; Schmidt M; Monninkhof EM; Puente MP; Clauss D; Zimmer P; Belloso J; Trevaskis M; Rundqvist H; Wiskemann J; Mueller J; Fremd C; Altena R; Kufel-Grabowska J; Bijlsma RM; van Leeuwen-Snoeks L; Ten Bokkel-Huinink D; Sonke G; Mann B; Francis P; Richardson G; Malter W; Lopez IMA; van der Wall E; Aaronson N; Senkus E; Urruticoechea A; Zopf E; Bloch W; Stuiver MM; Wengstrom Y; May A; Steindorf K
- Conference publication: ONCOLOGY RESEARCH AND TREATMENT. 2024;47:198Depenbusch J; Sweegers MG; Aaronson N; Wengstroem Y; Backman M; Gunasekara N; Clauss D; Schranz M; Buechler B; Arraras JI; Puente MP; Lachowicz M; May A; Stuiver MM; Steindorf K
- Editorial: JAMA ONCOLOGY. 2023;9(9):1199-1201Wengstroem Y; Fornander T; Lindstroem LS
- Conference publication: ONCOLOGY RESEARCH AND TREATMENT. 2023;46(SUPPL 3)Depenbusch J; Sweegers MG; Aaronson NK; Wengstroem Y; Backman M; Arraras JI; Schranz M; Buechler B; Lachowicz M; May AM; Stuiver MM; Steindorf K
- Study protocol: TRIALS. 2023;24(1):116Kotte M; Bolam KA; Mijwel S; Altena R; Cormie P; Wengstrom Y
- Study protocol: PLOS ONE. 2022;17(10):e0274804de Boniface J; Altena R; Ringborg CH; Bolam KA; Wengstrom Y
- Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S1261Depenbusch J; Sweegers M; Aaronson N; Wengstrom Y; Backman M; Arraras JI; Schranz M; Buechler B; Lachowicz M; May AM; Steindorf K; Stuiver M
- Meeting abstract: ANNALS OF ONCOLOGY. 2022;33(7):S1360-S1361Ullgren H; Wengstrom Y
- Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S1259Sweegers M; Depenbusch J; Aaronson N; Wengstrom Y; Backman M; Gunasekara N; Clauss D; Pelaez M; Lachowicz M; May AM; Steindorf K; Stuiver M
- Study protocol: TRIALS. 2022;23(1):610Hiensch AE; Monninkhof EM; Schmidt ME; Zopf EM; Bolam KA; Aaronson NK; Belloso J; Bloch W; Clauss D; Depenbusch J; Lachowicz M; Pelaez M; Rundqvist H; Senkus E; Stuiver MM; Trevaskis M; Urruticoechea A; Rosenberger F; van der Wall E; de Wit GA; Zimmer P; Wengstrom Y; Steindorf K; May AM
- Visa fler
Forskningsbidrag
- Physical exercise during neoadjuvant chemotherapy for breast cancer as a means to increase pathological complete response rates: the randomized Neo-ACT trial.Cancerfonden1 mars 2026 - 1 mars 2028
- Swedish Cancer Society1 januari 2023Physical exercise has a protective effect against cancer recurrence and survival. Effects of physical training reduce systemic inflammation and increase anti-tumoral cell function as well as immune cell function. The effect of a training session in humans releases immune cells into the blood circulation, in mouse models where training has been tested effects can be demonstrated on reduced tumor growth. Physical training affects the possibility of undergoing chemotherapy without reducing the dose due to side effects, thus increasing the effect of the treatment on the tumor through anti-inflammatory effects and increasing the possibility of a full dose of the chemotherapy. Neoadjuvant chemotherapy is standard treatment today for patients with tumors larger than 20 mm and/or spread to lymph nodes. Evaluation of the effectiveness of neoadjuvant treatment is done by examining the effect on the tumor if there is any invasive tissue remaining after the treatment (pCR). The purpose of the study is to influence the effectiveness of the neoadjuvant treatment during ongoing treatment and thus reduce the need for locoregional treatment through physical exercise - a lifestyle intervention with few side effects. The effect of physical training on the effectiveness of neoadjuvant treatment has previously never been tested. The goal of the study is to study whether the training can improve the outcome of the treatment in a clinically relevant way. Quality of life, physical activity levels, muscle strength and fitness, side effects, cognitive impact, heart health and sick leave are also examined. The study will also investigate in a group of the participants how exercise affects anti-tumoral mechanisms that are important for the treatment through hypothesis-generating translational analyses.
- European Commission1 november 2022 - 31 oktober 2027With over 12 million cancer survivors relying on supportive care across the EU, it is essential to provide them with (cost-)effective interventions tailored to their specific needs. Many survivors suffer from long-term side effects that can lower their quality of life (QoL), functioning, and productivity. Exercise interventions have proven to be uniquely beneficial in managing both physical and psychological complaints. However, their effects are strongest when tailored to a patient's specific burden, e.g. fatigue, low physical fitness, anxiety and depressive symptoms or chemotherapy-induced peripheral neuropathy. Moreover, the use of exercise interventions in supportive cancer care is still limited due to a lack of availability, a lack of accessibility caused by time and travel constraints and low awareness. To tackle these hurdles, the PREFERABLE-II consortium sets out to design and demonstrate the (cost-)effectiveness of a novel exercise intervention that: 1) will be tailored to the side effect that bothers the survivor the most, by use of a modular design, 2) can be implemented at home, with live-remote supervision from a national broadcast centre, 3) is available to all cancer survivors, and 4) incorporates improved patient-centred communication and shared decision making. Results of our RCT, enrolling 350 cancer survivors, will be translated into guideline recommendations for exercise-oncology. Extensive ethical, legal and social impact components of the project will reveal barriers and facilitators of live-remote supervised exercise and provide policy recommendations to further support implementation. Finally, we will create communication standards and an education module for healthcare professionals to train the future workforce. As such, PREFERABLE-II contributes to improving the QoL of cancer survivors by lowering the burden of side effects, while also improving availability, access and awareness off exercise-based supportive care interventions.
- Swedish Research Council1 december 2021 - 30 november 2025
- Swedish Cancer Society1 januari 2020Advances in cancer therapy have led to more people surviving cancer. As cancer treatments become more effective, but also more aggressive, it also means that more people suffer from negative long-term effects such as disabilities, late side effects and symptoms of the treatment, which leads to a negative impact on quality of life and daily life. Physical exercise is an intervention that can counteract several of these harmful effects. There is today a demand among those who have undergone treatment for cancer to participate in customized training programs led by trained trainers, which today does not exist for people with cancer in Sweden. The purpose of the Ex-Med Cancer project is to develop, implement and evaluate a sustainable model for supportive care for patients with cancer by implementing evidence-based exercise medicine in existing exercise organizations in society that can be implemented and run by trained exercise leaders. People with various cancer diagnoses who have undergone adjuvant treatment for cancer will follow a care plan that involves four different partsa referral, contact with a central coordinator, screening and a meeting with a training specialist at a gym (SATS) for participation in a 3-month training program. The results of the study will help people with cancer to gain access to evidence-based exercise medicine that is easily accessible in society with the support of exercise-specialized leaders. The results of the study will provide a basis for a national implementation of evidence-based training available to anyone who is diagnosed with cancer.
- Swedish Research Council1 januari 2019 - 31 december 2021
- Implementing exercise in cancer care - a community based exercise program for people with cancer - ExMed CancerSwedish Cancer Society1 januari 2019Advances in cancer therapy have led to more people surviving cancer. As cancer treatments become more effective, but also more aggressive, it also means that more people suffer from negative long-term effects such as disabilities, late side effects and symptoms of the treatment, which leads to a negative impact on quality of life and daily life. Physical exercise is an intervention that can counteract several of these harmful effects. There is today a demand among those who have undergone treatment for cancer to participate in customized training programs led by trained trainers, which today does not exist for people with cancer in Sweden. The purpose of the Ex-Med Cancer project is to develop, implement and evaluate a sustainable model for supportive care for patients with cancer by implementing evidence-based exercise medicine in existing exercise organizations in society that can be implemented and run by trained exercise leaders. People with various cancer diagnoses who have undergone adjuvant treatment for cancer will follow a care plan that involves four different partsa referral, contact with a central coordinator, screening and a meeting with a training specialist at a gym (SATS) for participation in a 3-month training program. The results of the study will help people with cancer to gain access to evidence-based exercise medicine that is easily accessible in society with the support of exercise-specialized leaders. The results of the study will provide a basis for a national implementation of evidence-based training available to anyone who is diagnosed with cancer.
- Swedish Research Council1 januari 2015 - 31 december 2017
Anställningar
- Professor, Omvårdnad, Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2015-
- Acting Director of Nursing, Neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2015-2019
Examina och utbildning
- Docent, Omvårdnad, Karolinska Institutet, 2008
- MEDICINE DOKTORSEXAMEN, Institutionen för onkologi-patologi, Karolinska Institutet, 2000
Handledning
Handledning till doktorsexamen
- Matilda Appelgren, De-escalation of axillary surgery in breast cancer: patient experiences, arm morbidity, and health-related quality of life., 2025
- Mattias Hammarström, Investigating the outcome of low and standard dose tamoxifen in healthy women, 2021-
- Martina Rossland
- Lea Stark